See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2019_Adamas_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001328143')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 228,373,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 3,652,000 |
3 | remainder_Assets | 2,789,000 |
4 | LiabilitiesCurrent | 24,276,000 |
5 | LiabilitiesNoncurrent | 120,653,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 633,000 |
8 | SellingGeneralAndAdministrativeExpense | 109,135,000 |
9 | ResearchAndDevelopmentExpense | 39,300,000 |
10 | remainder_Expenses | 15,977,000 |
11 | remainder_Revenues | 34,046,000 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | -97,000 |
yvar | yval | |
---|---|---|
0 | Assets | 234,814,000 |
1 | Liabilities | 144,929,000 |
2 | Expenses | 165,045,000 |
3 | Revenues | 34,046,000 |
4 | StockholdersEquity | 89,885,000 |
5 | NetIncome | -130,999,000 |
6 | ComprehensiveNetIncome | -131,047,500 |
7 | BaseVar | 289,465,500 |
8 | EconomicCapitalRatio | 0.124 |